Results 161 to 170 of about 7,953 (182)

Allosteric regulation of [3H]acetylcholine binding to m2 muscarinic receptors

Life Sciences, 1993
J. Ellis, A.L. Gnagey, L. First, M. Seidenberg   +3 more
openaire   +1 more source

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

M2 Muscarinic Acetylcholine Receptor

2007
openaire   +1 more source

Design and Synthesis of Novel Ligands for the M2 Muscarinic Acetylcholine Receptor

2020
The M2 muscarinic acetylcholine receptor (M2R) belongs to a highly conserved five-membered family within the class A of G protein-coupled receptors (GPCRs).5-7 The five subtypes are ubiquitously expressed and play a key role in numerous physiological processes.15, 17, 18 Upon activation, the M2R causes, among other things, negative chronotropy and ...
openaire   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Targeting receptor complexes: a new dimension in drug discovery

Nature Reviews Drug Discovery, 2020
Mette Ishøy Rosenbaum, Louise Albertsen, David S Bredt   +2 more
exaly  

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

Nature Reviews Drug Discovery, 2011
Uwe Rudolph
exaly  

Development of subtype-selective oestrogen receptor-based therapeutics

Nature Reviews Drug Discovery, 2011
Jan-Ake Gustafsson
exaly